They focus on companies with proprietary compounds or products that have the potential to become new therapeutics, as well as product platform companies that use proprietary technologies to discover new drug candidates. While they invest in companies across all geographical areas, they have a preference for companies in Southern California, Boston, the San Francisco Bay area, and the greater Washington D.C. area. Coastview Capital typically invests between $1 million to $5 million initially and up to $10 million over the life of the company. They consider direct equity investments in companies at all stages. The firm is based in Los Angeles, California.